Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05706909 · ClinicalTrials.gov registry record
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
A clinical trial of Avascular Necrosis and Osteonecrosis, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT05706909 is a study of Avascular Necrosis and Osteonecrosis that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 22 participants, below the 294-participant average among 24 other Avascular Necrosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05706909, a study of Avascular Necrosis and Osteonecrosis, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the clinical and x-ray results of patients who are treated with core decompression of the hip and the injection of a bone marrow concentrate and the use of the Bone Graft Substitute Genex®.
Conditions Studied
Interventions
- DEVICE Genex with ABMC
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-02-08 |
| Est. Completion | 2027-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05706909
The ClinicalTrials.gov registry entry for NCT05706909 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 294-participant average among 24 other Avascular Necrosis trials with a reported enrollment target (93% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Avascular Necrosis appearing as the primary indexed condition, and to 1 intervention - of which Genex with ABMC is the first listed.
NCT05706909 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05706909 about?
NCT05706909 is a clinical study titled "The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head". The purpose of this study is to assess the clinical and x-ray results of patients who are treated with core decompression of the hip and the injection of a bone marrow concentrate and the use of the Bone Graft Substitute Genex®.
What is the current status of trial NCT05706909?
This trial is currently active not recruiting. The enrollment target is 22 participants. The study started on 2023-02-08. Estimated completion is 2027-07.
What conditions does trial NCT05706909 study?
This clinical trial studies the following conditions: Avascular Necrosis, Osteonecrosis.
What interventions are being tested in trial NCT05706909?
The interventions under investigation include: Genex with ABMC (DEVICE).
Who is sponsoring clinical trial NCT05706909?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05706909 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avascular Necrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
RECRUITING · Phase 2
-
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
RECRUITING
-
Perform Humeral System Study
RECRUITING
-
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
ACTIVE NOT RECRUITING
-
Sickle Cell Disease (SCD) Bone Pain Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.